ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2020 and some content may be unavailable. To unlock all content for 2020, please visit the archives.

Abstract: PO0455

The Phosphate-to-Urinary Urea Nitrogen Ratio (P/UUN): A Tool to Evaluate Phosphate Intake and Excretion in CKD Patients

Session Information

Category: CKD (Non-Dialysis)

  • 2101 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Pendon-Ruiz de Mier, Victoria, Instituto Maimonides de Investigacion Biomedica de Cordoba, Cordoba, Andalucía, Spain
  • Rodelo-Haad, Cristian, Instituto Maimonides de Investigacion Biomedica de Cordoba, Cordoba, Andalucía, Spain
  • Santamaria, Rafael, Instituto Maimonides de Investigacion Biomedica de Cordoba, Cordoba, Andalucía, Spain
  • López baltanás, Rodrigo, Instituto Maimonides de Investigacion Biomedica de Cordoba, Cordoba, Andalucía, Spain
  • Membrives González, Cristina, Instituto Maimonides de Investigacion Biomedica de Cordoba, Cordoba, Andalucía, Spain
  • Munoz-Castaneda, Juan R., Instituto Maimonides de Investigacion Biomedica de Cordoba, Cordoba, Andalucía, Spain
  • Martin-Malo, Alejandro, Instituto Maimonides de Investigacion Biomedica de Cordoba, Cordoba, Andalucía, Spain
  • Soriano, Sagrario, Instituto Maimonides de Investigacion Biomedica de Cordoba, Cordoba, Andalucía, Spain
  • Rodriguez Portillo, Mariano, Instituto Maimonides de Investigacion Biomedica de Cordoba, Cordoba, Andalucía, Spain
Background

Phosphate (P) restriction is crucial in CKD patients. Classically, P intake has failed to correlate with 24-h phosphaturia. Organic or inorganic P have different intestinal absorption rates, which might explain the lack of correlation between P intake and phosphaturia. Thus, we aimed to evaluate if the source of dietary P rather than the total P ingested determines phosphaturia, and to what extent inorganic P intake modifies phosphaturia

Methods

A 3-day dietary survey was performed in 71 stages G2-3 CKD patients to estimate the amount and source of P intake. 24-h urine samples were collected. Total phosphaturia, the FeP(%), and P/UUN, which reflect intestinal absorption of P relative to proteins absorbed and metabolized), were evaluated. P/UUN ratio tertiles were contrasted with the other variables analyzed (T1<58.9mg/g,T2=58.9-71.1mg/g,T3>71.1mg/g). Statistics were performed using Rv3.6.2

Results

The P intake was 1086.5±361.3 mg/day. P intake was 64.0%,22.1%, and 14.1% from animal, vegetables, and inorganic sources respectively. Total P intake did not correlate with urinary P (p=0.12), nor FeP. Patients ingesting more P ingested more inorganic P (Fig1). P intake correlated with P/UUN ratio(p=0.008). Patients in the upper P/UUN tertile showed the highest daily P intake (p=0.04) from inorganic sources (p=0.03), and the highest phosphaturia (p=0.04)

Conclusion

P/UUN reflects the total P intake and provides information about the amount of inorganic P, and could be used to guide the appropriate nutritional advice for CKD patients.

Fig1 Correlation between P intake and the different sources. A. Animal, B. Vegetal, C. Inorganic